Relationship Between ORI and Blood Transfusion in Spinal Surgery

NCT ID: NCT05868447

Last Updated: 2023-05-22

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 100 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2022-12-15
• Study Completion Date: 2023-06-15

Brief Summary

Concerns about the necessity and risks of blood transfusions have led to the search for new noninvasive monitoring methods. Oxygen reserve index (ORI), one of them, is a dimensionless index ranging from 0.00 (no reserve) to 1.00 (maximum reserve) according to oxygenation reserve status, and it is also a non-invasive and continuous measurement parameter. Some studies have examined ORi as an indicator for early detection of hypoxemia. There are reports in the literature that ORi and Pa02 values measured noninvasively during surgery are early precursors for desaturation and hypoxia.Researces aimed to investigate the relationship between perioperative blood transfusions and ORI in vertebral stabilization surgeries performed by the same surgical team in our clinic.

Detailed Description

With the increase in the elderly population in the world, the incidence of vertebral deformities is increasing and vertebral surgery has become one of the most commonly performed surgeries. Blood loss in vertebral and spinal canal deformity surgeries varies according to the surgical procedure, duration of operation and type of anesthesia. With the increase in blood loss, blood and blood product transfusion also increases. Although many technical and pharmacological methods have been applied to reduce blood transfusion in surgical patients, there is still no consensus on when to transfuse, and there are still institutional and individual differences in transfusion practices. In the literature, there are studies showing that some centers never use blood for the same surgery in patients, while in other centers blood is almost always used [4]. This has led to the comment that "Blood transfusion is a practice that takes place according to the physician, not the patient." The World Health Organization (WHO) defines anemia as hemoglobin (Hb) concentration <13 g/dl for men and <12 g/dl for women. Although these Hb concentrations stated in the literature try to define the lowest acceptable hemoglobin, transfusion practices are based on multiple physiologic parameters (tachycardia, hypotension, ST segment changes) rather than an isolated laboratory measurement (Hb and hematocrit values), The decision to transfuse blood is known to be difficult to standardize as it has to be made taking into account the need for increased oxygen extraction rate, new-onset wall motion abnormalities on transesophageal echocardiography, cardiac output and oxygen content of arterial blood, central venous oxygen saturation, base deficit, lactate level, etc.). The decision to transfuse blood is based on the hope of increasing tissue oxygen delivery (DO2), followed by cellular oxygenation. Improving DO2 has been shown to reduce both morbidity and mortality in the perioperative period. Tailoring DO2 to O2 consumption using specific targets seems promising. The common criterion used to start blood transfusion therapy is to determine the Hb level and to show that the DO2 has fallen to the critical Hb level, which is assumed to be compromised. With this view triggered by the Hb level detected at the critical level, transfusion is performed and it is seen that the Hb level is increased to a safe level after transfusion. Although it can be easily demonstrated that transfusion therapy increases Hb level and consequently DO2, it requires further research to determine how this treatment reflects on the general oxygen supply/consumption balance. Indeed, for this purpose, monitoring of mixed central venous oxygen saturation (SvO2) is a prerequisite. This method, which requires a pulmonary artery catheter, is currently used in very limited situations and indications and central venous saturation (ScvO2) value is generally used instead of SvO2.

Anesthesia management of the patients included in the study and the interventional procedures to be performed will be decided by the responsible anesthesiologist.

The initial ORI value of the patient will be determined as PO2 value between 100-120 mmHg in arterial blood gas (ABG) and will be recorded on the case report form every 15 minutes. The preoperative Hb value will also be recorded on the case report form, and in patients with intraoperative expected blood loss >500 ml and for whom blood transfusion is foreseen, the hemoglobin value and ORI value will be recorded by the responsible anesthesiologist at the time of the indication of erythrocyte transfusion. Accordingly, the relationship between the initial ORI value and the ORI value at the time of the decision for erythrocyte transfusion will be examined.

Conditions

Perioperative Hemorrhage

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Interventions

Stabilization surgery

hourly blood gas analysis and hemoglobin and hematocrit control and blood transfusion will be performed when necessary

If a low pO2 value is observed in the blood gas, the fi02 values or fresh gas flow will be increased.

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• Patients over 18 years of age in ASA I-III risk class
• Patients who will undergo vertebral stabilization surgery at 3 levels or more under general anesthesia (lumbar disc herniation, lumbar spinal stenosis, lumbar spondylolisthesis and other lumbar spine pathologies)
• who are expected to lose >500 ml of blood
• Patients who require arterial catheter placement for continuous monitoring of blood pressure and/or analysis of arterial blood gas during surgery

Exclusion Criteria

• Patients with coagulation disorders, thrombocytopenia, liver and kidney disease
• Patients receiving regular anticoagulant and antiplatelet therapy
• Patients who will undergo revision surgery
• Patients who will undergo surgery due to spinal tumor or infection
• Patients with perioperative tranexamic acid and/or antifibrinolytic use
• Patients with preoperative hemoglobin values <12 g/dl in women and <13 g/dl in men or patients with preoperative anemia due to hemoglobinopathies (e.g. thalassemia, sickle cell disease anemia)
• Patients with congestive heart failure
• Inability to attach the sensor due to deformity of the fingers
• Inability to attach the sensor due to hypoperfusion of the fingers: thalassemia, sickle cell disease anemia)
• Patients with congestive heart failure
• Inability to wear the sensor due to deformity of the fingers
• Patients who would show an inadequate signal due to hypoperfusion of the fingers were excluded.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Bursa Yuksek Ihtisas Training and Research Hospital

OTHER_GOV

Sponsor Role: lead

Responsible Party

Asiye Demirel

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Asiye A Demirel, MD

Role: PRINCIPAL_INVESTIGATOR

Bursa Yuksek Ihtisas Training and Research Hospital

Locations

Bursa Training and Research Hospital

Bursa, , Turkey (Türkiye)

Countries

Turkey (Türkiye)

Other Identifiers

2011- KAEK- 25 2022/12-10

Identifier Type: -

Identifier Source: org_study_id